Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Elife ; 112022 02 07.
Article in English | MEDLINE | ID: mdl-35129434

ABSTRACT

Before hearing onset (postnatal day 12 in mice), inner hair cells (IHCs) spontaneously fire action potentials, thereby driving pre-sensory activity in the ascending auditory pathway. The rate of IHC action potential bursts is modulated by inner supporting cells (ISCs) of Kölliker's organ through the activity of the Ca2+-activated Cl--channel TMEM16A (ANO1). Here, we show that conditional deletion of Ano1 (Tmem16a) in mice disrupts Ca2+ waves within Kölliker's organ, reduces the burst-firing activity and the frequency selectivity of auditory brainstem neurons in the medial nucleus of the trapezoid body (MNTB), and also impairs the functional refinement of MNTB projections to the lateral superior olive. These results reveal the importance of the activity of Kölliker's organ for the refinement of central auditory connectivity. In addition, our study suggests the involvement of TMEM16A in the propagation of Ca2+ waves, which may also apply to other tissues expressing TMEM16A.


Subject(s)
Anoctamin-1/metabolism , Brain Stem/metabolism , Calcium/metabolism , Cochlea/metabolism , Hearing , Neurons/metabolism , Action Potentials , Animals , Auditory Pathways , Brain Waves , Chloride Channels/metabolism , Hair Cells, Auditory/metabolism , Hair Cells, Auditory, Inner/metabolism , Mice , Mice, Knockout
2.
J Clin Invest ; 131(9)2021 05 03.
Article in English | MEDLINE | ID: mdl-33755596

ABSTRACT

GDP-mannose-pyrophosphorylase-B (GMPPB) facilitates the generation of GDP-mannose, a sugar donor required for glycosylation. GMPPB defects cause muscle disease due to hypoglycosylation of α-dystroglycan (α-DG). Alpha-DG is part of a protein complex, which links the extracellular matrix with the cytoskeleton, thus stabilizing myofibers. Mutations of the catalytically inactive homolog GMPPA cause alacrima, achalasia, and mental retardation syndrome (AAMR syndrome), which also involves muscle weakness. Here, we showed that Gmppa-KO mice recapitulated cognitive and motor deficits. As structural correlates, we found cortical layering defects, progressive neuron loss, and myopathic alterations. Increased GDP-mannose levels in skeletal muscle and in vitro assays identified GMPPA as an allosteric feedback inhibitor of GMPPB. Thus, its disruption enhanced mannose incorporation into glycoproteins, including α-DG in mice and humans. This increased α-DG turnover and thereby lowered α-DG abundance. In mice, dietary mannose restriction beginning after weaning corrected α-DG hyperglycosylation and abundance, normalized skeletal muscle morphology, and prevented neuron degeneration and the development of motor deficits. Cortical layering and cognitive performance, however, were not improved. We thus identified GMPPA defects as the first congenital disorder of glycosylation characterized by α-DG hyperglycosylation, to our knowledge, and we have unraveled underlying disease mechanisms and identified potential dietary treatment options.


Subject(s)
Dystroglycans , Guanosine Diphosphate Mannose , Muscle, Skeletal/metabolism , Neuromuscular Diseases , Nucleotidyltransferases/deficiency , Animals , Dystroglycans/genetics , Dystroglycans/metabolism , Glycosylation , Guanosine Diphosphate Mannose/genetics , Guanosine Diphosphate Mannose/metabolism , Humans , Mice , Mice, Knockout , Neuromuscular Diseases/diet therapy , Neuromuscular Diseases/genetics , Neuromuscular Diseases/metabolism , Nucleotidyltransferases/metabolism
3.
J Clin Invest ; 123(10): 4273-82, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24051375

ABSTRACT

Axonopathies are a group of clinically diverse disorders characterized by the progressive degeneration of the axons of specific neurons. In hereditary spastic paraplegia (HSP), the axons of cortical motor neurons degenerate and cause a spastic movement disorder. HSP is linked to mutations in several loci known collectively as the spastic paraplegia genes (SPGs). We identified a heterozygous receptor accessory protein 1 (REEP1) exon 2 deletion in a patient suffering from the autosomal dominantly inherited HSP variant SPG31. We generated the corresponding mouse model to study the underlying cellular pathology. Mice with heterozygous deletion of exon 2 in Reep1 displayed a gait disorder closely resembling SPG31 in humans. Homozygous exon 2 deletion resulted in the complete loss of REEP1 and a more severe phenotype with earlier onset. At the molecular level, we demonstrated that REEP1 is a neuron-specific, membrane-binding, and membrane curvature-inducing protein that resides in the ER. We further show that Reep1 expression was prominent in cortical motor neurons. In REEP1-deficient mice, these neurons showed reduced complexity of the peripheral ER upon ultrastructural analysis. Our study connects proper neuronal ER architecture to long-term axon survival.


Subject(s)
Endoplasmic Reticulum/metabolism , Membrane Transport Proteins/genetics , Motor Neurons/metabolism , Spastic Paraplegia, Hereditary/genetics , Animals , Base Sequence , Cell Membrane/chemistry , Cell Membrane/metabolism , Endoplasmic Reticulum/pathology , Exons , Gait , Humans , Membrane Transport Proteins/chemistry , Membrane Transport Proteins/metabolism , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Electron, Transmission , Molecular Sequence Data , Motor Neurons/pathology , Sequence Deletion , Spastic Paraplegia, Hereditary/pathology , Spinal Cord/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...